As the curtains close on 2025, it’s time to reflect on how the year unfolded. BioSpectrum encapsulates some of the key trends for 2026, starting with the reigning behemoth, China.
To understand what lies ahead for the life-sciences sector, BioSpectrum Asia spoke with analysts from across its major market segments. Their insights reveal key predictions spanning pharma, biotech, medtech, healthcare, digital health, and manufacturing.
These forces are expected to define the region’s innovation, investment momentum, and regulatory shifts in the year to come. Let’s dive deeper.
Explore the Issue